Peter Johann

Peter Johann is the founder of Lumendi Ltd. since 2014, holding the title of Chairman & Chief Executive Officer.
Current jobs include Director at Vivaldi Biosciences, Inc., Director-Supervisory Board at TME Pharma AG since 2014, Director at Exosome Diagnostics, Inc., Managing General Partner at NGN Capital LLC since 2004, and Member-Supervisory Board at Vivaldi Biosciences AG.
Former jobs include Chairman at Resverlogix Corp.
from 2010 to 2016, Director at Zenith Capital Corp.
(Alberta), Director at Horizon Therapeutics Switzerland GmbH, Director at Amgen Rockville, Inc. from 2006 to 2011, Director at ENDOSENSE SA, Director at NaniRx Therapeutics, Inc., Head-Business Development & Marketing at Roche Holding AG, Head-Business Development & Marketing at Molecular Medicine BioServices, Inc. from 1996 to 1998, Member-Supervisory Board at Shire Orphan Therapies GmbH, Head-Business Development at Roche Diagnostics GmbH in 1998, and Divisional Head-Corporate Development at Boehringer Ingelheim Corp.
from 2000 to 2004.
Education includes a doctorate from Technische Universität München.